| Combination therapy for treatment of infections with gram-negative bacteria PD Tamma, SE Cosgrove, LL Maragakis Clinical microbiology reviews 25 (3), 450-470, 2012 | 959 | 2012 |
| Association of adverse events with antibiotic use in hospitalized patients PD Tamma, E Avdic, DX Li, K Dzintars, SE Cosgrove JAMA internal medicine 177 (9), 1308-1315, 2017 | 707 | 2017 |
| Infectious Diseases Society of America guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales … PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D Van Duin, CJ Clancy Clinical Infectious Diseases 72 (7), e169-e183, 2021 | 578 | 2021 |
| Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections PD Tamma, EL Heil, JA Justo, AJ Mathers, MJ Satlin, RA Bonomo Clinical infectious diseases, ciae403, 2024 | 555 | 2024 |
| Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and … PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D Van Duin, CJ Clancy Clinical infectious diseases 74 (12), 2089-2114, 2022 | 498 | 2022 |
| Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia PD Tamma, KE Goodman, AD Harris, T Tekle, A Roberts, A Taiwo, ... Clinical Infectious Diseases 64 (3), 257-264, 2017 | 431 | 2017 |
| Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant … PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D Van Duin, CJ Clancy Clinical Infectious Diseases 75 (2), 187-212, 2022 | 395 | 2022 |
| Safety of influenza vaccination during pregnancy PD Tamma, KA Ault, C del Rio, MC Steinhoff, NA Halsey, SB Omer American journal of obstetrics and gynecology 201 (6), 547-552, 2009 | 370 | 2009 |
| Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia PD Tamma, JH Han, C Rock, AD Harris, E Lautenbach, AJ Hsu, E Avdic, ... Clinical Infectious Diseases 60 (9), 1319-1325, 2015 | 368 | 2015 |
| Multicenter initial guidance on use of antivirals for children with coronavirus disease 2019/severe acute respiratory syndrome coronavirus 2 K Chiotos, M Hayes, DW Kimberlin, SB Jones, SH James, SG Pinninti, ... Journal of the Pediatric Infectious Diseases Society 9 (6), 701-715, 2020 | 325 | 2020 |
| Phenotypic detection of carbapenemase-producing organisms from clinical isolates PD Tamma, PJ Simner Journal of clinical microbiology 56 (11), 10.1128/jcm. 01140-18, 2018 | 297 | 2018 |
| Considerations for the use of phage therapy in clinical practice GA Suh, TP Lodise, PD Tamma, JM Knisely, J Alexander, S Aslam, ... Antimicrobial agents and chemotherapy 66 (3), e02071-21, 2022 | 281 | 2022 |
| A primer on AmpC β-lactamases: necessary knowledge for an increasingly multidrug-resistant world PD Tamma, Y Doi, RA Bonomo, JK Johnson, PJ Simner, ... Clinical infectious diseases 69 (8), 1446-1455, 2019 | 258 | 2019 |
| Antimicrobial stewardship PD Tamma, SE Cosgrove Infectious Disease Clinics 25 (1), 245-260, 2011 | 241 | 2011 |
| What is the more effective antibiotic stewardship intervention: preprescription authorization or postprescription review with feedback? PD Tamma, E Avdic, JF Keenan, Y Zhao, G Anand, J Cooper, R Dezube, ... Clinical Infectious Diseases 64 (5), 537-543, 2017 | 209 | 2017 |
| The safety and toxicity of phage therapy: a review of animal and clinical studies D Liu, JD Van Belleghem, CR de Vries, E Burgener, Q Chen, ... Viruses 13 (7), 1268, 2021 | 205 | 2021 |
| Treatment of multidrug-resistant Gram-negative infections in children AJ Hsu, PD Tamma Clinical infectious diseases 58 (10), 1439-1448, 2014 | 203 | 2014 |
| The use of noncarbapenem β-lactams for the treatment of extended-spectrum β-lactamase infections PD Tamma, J Rodriguez-Baňo Clinical Infectious Diseases 64 (7), 972-980, 2017 | 194 | 2017 |
| A clinical decision tree to predict whether a bacteremic patient is infected with an extended-spectrum β-lactamase–producing organism KE Goodman, J Lessler, SE Cosgrove, AD Harris, E Lautenbach, JH Han, ... Clinical Infectious Diseases 63 (7), 896-903, 2016 | 190 | 2016 |
| Comparing the outcomes of adults with Enterobacteriaceae bacteremia receiving short-course versus prolonged-course antibiotic therapy in a multicenter, propensity score–matched … D Chotiprasitsakul, JH Han, SE Cosgrove, AD Harris, E Lautenbach, ... Clinical infectious diseases 66 (2), 172-177, 2018 | 189 | 2018 |
